2m 2m 2m 2m 2m 2m 2m
ALECTOR (ALEC)
NASDAQ
$1.82-$0.02 (-0.82%)
Price as of Jun 23, 2026 7:58 PM EDT- $197.6MMarket Cap
- 22.82%1-Year Change
- BiotechnologyIndustry
ALECTOR (ALEC)
$1.82-$0.02 (-0.82%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 21.0M -79.07% | 100.6M +3.60% | 97.1M -27.36% | 133.6M -35.48% | |
Cost of Revenue | N/A N/A | N/A N/A | 0 N/A | N/A N/A | |
Gross Profit | 21.0M -79.07% | 100.6M +3.60% | 97.1M -27.36% | 133.6M -35.48% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -123.1M -33.81% | -185.9M -3.21% | -192.1M -8.70% | -210.4M +11.09% | |
Depreciation and Amortization Expense | 5.7M +5.75% | 5.4M -5.55% | 5.7M +0.19% | 5.7M -9.72% | |
Total Operating Expenses | 177.1M -27.90% | 245.6M -1.31% | 248.8M -8.34% | 271.5M +11.05% | |
Operating Profit | -156.0M +7.59% | -145.0M -4.44% | -151.7M +10.09% | -137.8M +268.93% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 13.2M -49.20% | 26.1M -1.83% | 26.6M +241.49% | 7.8M +654.41% | |
Income before Taxes | -142.8M +20.05% | -118.9M -5.00% | -125.2M -3.75% | -130.1M +248.12% | |
Income Taxes | 168,000 +31.25% | 128,000 -97.54% | 5.2M +60.17% | 3.3M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -142.9M +20.06% | -119.0M -8.70% | -130.4M -2.19% | -133.3M +266.95% | |
Net Income from Continuing Operations Applicable to Common | -142.9M +20.06% | -119.0M -8.70% | -130.4M -2.19% | -133.3M +266.95% | |
Basic EPS and Net Income | -1.39 +13.01% | -1.23 -21.15% | -1.56 -3.70% | -1.62 +260.00% | |
Diluted EPS and Net Income | -1.39 +13.01% | -1.23 -21.15% | -1.56 -3.70% | -1.62 +260.00% | |
Basic Weighted Average Shares | 103.0M +6.64% | 96.6M +15.35% | 83.7M +1.54% | 82.5M +2.55% | |
Diluted Weighted Average Shares | 103.0M +6.64% | 96.6M +15.35% | 83.7M +1.54% | 82.5M +2.55% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 65.8M +99.27% | 33.0M -55.71% | 74.6M -51.69% | 154.3M -53.11% | |
Short-Term Investments | 190.2M -49.99% | 380.4M -19.80% | 474.3M -15.08% | 558.5M +37.53% | |
Cash and Cash Equivalents and Short-Term Investments | 256.0M -38.07% | 413.4M -24.68% | 548.9M -23.00% | 712.9M -3.05% | |
Total Current Assets | 266.5M -37.28% | 424.8M -24.92% | 565.8M -22.11% | 726.4M -3.10% | |
Accumulated Depreciation | 37.5M +13.82% | 32.9M +17.44% | 28.1M +24.05% | 22.6M +30.81% | |
Property and Plant and Equipment and Net | 10.8M -36.77% | 17.1M -21.57% | 21.9M -14.34% | 25.5M -6.62% | |
Total Long-Term Assets | 386,000 -91.51% | 4.5M -38.74% | 7.4M +15.74% | 6.4M +14.98% | |
Total Assets | 293.2M -37.38% | 468.3M -24.69% | 621.8M -21.05% | 787.6M -3.32% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 366,000 N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Current Liabilities | 69.5M -44.42% | 125.1M -29.72% | 177.9M +89.69% | 93.8M -32.78% | |
Total Long-Term Debt | 9.3M -0.70% | 9.4M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.7M +40.76% | 1.2M -10.12% | 1.4M +80.90% | 759,000 +380.38% | |
Total Liabilities | 262.6M -23.11% | 341.5M -29.97% | 487.7M -14.92% | 573.2M +11.53% | |
Retained Earnings | -972.1M +17.24% | -829.1M +16.77% | -710.1M +22.49% | -579.7M +29.86% | |
Total Stockholders Equity | 30.6M -75.83% | 126.8M -5.48% | 134.2M -37.44% | 214.4M -28.69% | |
Total Shares Outstanding | 110.4M +11.38% | 99.1M +16.74% | 84.9M +3.53% | 82.0M +3.37% | |
Cash Flow | |||||
Cash from Operating Activities | -184.0M -19.95% | -229.9M +24.84% | -184.2M +805.91% | -20.3M -106.81% | |
Capital Expenditures | 41,000 -96.73% | 1.3M -47.29% | 2.4M -42.17% | 4.1M +26.79% | |
Cash from Investing Activities | 196.6M +83.51% | 107.1M +5.11% | 101.9M +164.09% | -159.0M +220.19% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 20.2M -75.21% | 81.5M +3,097.65% | 2.5M -43.51% | 4.5M -85.10% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | 100.00% N/A | N/A N/A | |
Operating Margin | -741.30% +414.11% | -144.19% -7.77% | -156.33% +51.55% | -103.16% +471.79% | |
Return on Assets | -37.54% +71.86% | -21.84% +18.05% | -18.50% +11.19% | -16.64% +198.39% | |
Return on Equity | -181.56% +98.99% | -91.24% +21.96% | -74.81% +44.55% | -51.75% +304.77% | |
Revenue Growth | -79.07% -2,295.34% | 3.60% +113.17% | -27.36% -22.89% | -35.48% -104.02% | |
Current Ratio | 3.83 +12.86% | 3.40 +6.83% | 3.18 -58.94% | 7.74 +44.15% | |
Cash Ratio | 0.95 +258.64% | 0.26 -36.99% | 0.42 -74.53% | 1.65 -30.25% | |
Debt-to-Equity Ratio | 0.32 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.03 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow